The US Food and Drug Administration (FDA) has approved a once-daily combination of dapagliflozin and metformin hydrochloride extended-release (Xigduo XR, AstraZeneca) for the treatment of adults with type 2 diabetes.
FDA Approves Xigduo XR, a New Dapagliflozin-Metformin Combination for TII